Biomedical Science Letters (대한의생명과학회지)

The Korean Society for Biomedical Laboratory Sciences (대한의생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Establishment of Highly Tumorigenic Human Gastric Carcinoma Cell Lines from Xenograft Tumors in Mice

  • Song, Kyung-A (Philips Institute for Oral Health Research, Virginia Commonwealth University School of Dentistry) ;
  • Park, Jihyun (Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University) ;
  • Kim, Ha-Jung (Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kang, Myung Soo (Institute of Life Technology, Intron Biotechnology Inc.) ;
  • Kim, Sun Young (Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2017.07.19
  • Accepted : 2017.08.24
  • Published : 2017.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Patient's primary tumor-derived tumor cell lines likely represent ideal tools for human tumor biology in vitro and in vivo. Here, we describe eight human gastric carcinoma cell lines derived from established tumors in vivo upon subcutaneous transplantation of primary gastric carcinoma specimens in BALB/c nude mice. These xenografted gastric tumor cell lines (GTX) displayed close similarity with primary gastric tumor tissues in their in vivo growth pattern and genomic alterations. GTX-085 cells were resistant to cisplatin, while GTX-087 was the most sensitive cell line. GTX-085 was the only cell line showing a metastatic potential. Epithelial cell adhesion molecule (EPCAM) expression was especially strong in all tissue samples, as well as in cell cultures. GTX-139, the largest tumor graft obtained after injection, displayed distinct expression of CD44v6, fibroblast growth factor receptor 2 (FGFR2), and prominin 1 (PROM1, also known as CD133). In summary, we established eight xenograft gastric cancer cell lines from gastric cancer patient tissues, with their histological and molecular features consistent with those of the primary tumors. The established GTX cell lines will enable future studies of their responses to various treatments for gastric cancer.

Keywords

References

  1. Dangles-Marie V, Pocard M, Richon S, Weiswald LB, Assayag F, Saulnier P, Judde JG, Janneau JL, Auger N, Validire P, Dutrillaux B, Praz F, Bellet D, Poupon MF. Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features. Cancer Research. 2007. 67: 398-407. https://doi.org/10.1158/0008-5472.CAN-06-0594
  2. Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM, Yung R, Parmigiani G, Dorsch M, Peacock CD, Watkins DN. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Research. 2009. 69: 3364-3373. https://doi.org/10.1158/0008-5472.CAN-08-4210
  3. Fidler IJ. Critical determinants of metastasis. Seminars in Cancer Biology. 2002. 12: 89-96. https://doi.org/10.1006/scbi.2001.0416
  4. Fukayama M. Epstein-Barr virus and gastric carcinoma. Pathology International. 2010. 60: 337-350. https://doi.org/10.1111/j.1440-1827.2010.02533.x
  5. Jung D, Cho Y, Kim TU, Sa Jeong SH. Gene expression analysis from the normal stomach cells treated with a cancer inducer N-methyl-N'-nitro-N-nitrosoguanidine, MNNG. Biomedical Science Letters. 2017. 23: 30-33. https://doi.org/10.15616/BSL.2017.23.1.30
  6. Kodama H, Murata S, Ishida M, Yamamoto H, Yamaguchi T, Kaida S, Miyake T, Takebayashi K, Kushima R, Tani M. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer. British Journal of Cancer. 2017. 116:186-194. https://doi.org/10.1038/bjc.2016.401
  7. Ku JL, Kim KH, Choi JS, Kim SH, Shin YK, Chang HJ, Bae JM, Kim YW, Lee JH, Yang HK, Kim WH, Jeong SY, Park JG. Establishment and characterization of six human gastric carcinoma cell lines, including one naturally infected with Epstein-Barr virus. Cellular Oncology (Dordrecht). 2012. 35:127-136. https://doi.org/10.1007/s13402-012-0073-9
  8. Lee EK, Song KA, Chae JH, Kim KM, Kim SH, Kang MS. GAGE12 mediates human gastric carcinoma growth and metastasis. International Journal of Cancer. 2015. 136: 2284-2292. https://doi.org/10.1002/ijc.29286
  9. Lin CT, Dee AN, Chen W, Chan WY. Association of Epstein-Barr virus, human papilloma virus, and cytomegalovirus with nine nasopharyngeal carcinoma cell lines. Laboratory Investigation. 1994. 71: 731-736.
  10. Nakanishi H, Yasui K, Ikehara Y, Yokoyama H, Munesue S, Kodera Y, Tatematsu M. Establishment and characterization of three novel human gastric cancer cell lines with differentiated intestinal phenotype derived from liver metastasis. Clinical and Experimental Metastasis. 2005. 22: 137-147. https://doi.org/10.1007/s10585-005-6526-z
  11. Oh ST, Cha JH, Shin DJ, Yoon SK, Lee SK. Establishment and characterization of an in vivo model for Epstein-Barr virus positive gastric carcinoma. Journal of Medical Virology. 2007. 79: 1343-1348. https://doi.org/10.1002/jmv.20876
  12. Park JG, Frucht H, LaRocca RV, Bliss DP, Jr., Kurita Y, Chen TR, Henslee JG, Trepel JB, Jensen RT, Johnson BE, Bang YJ, Kim JP, Gazdar AF. Characteristics of cell lines established from human gastric carcinoma. Cancer Research. 1990. 50: 2773-2780.
  13. Park JG, Yang HK, Kim WH, Chung JK, Kang MS, Lee JH, Oh JH, Park HS, Yeo KS, Kang SH, Song SY, Kang YK, Bang YJ, Kim YH, Kim JP. Establishment and characterization of human gastric carcinoma cell lines. International Journal of Cancer. 1997. 70: 443-449. https://doi.org/10.1002/(SICI)1097-0215(19970207)70:4<443::AID-IJC12>3.0.CO;2-G
  14. Richmond A, Su Y. Mouse xenograft models vs gem models for human cancer therapeutics. Disease Models & Mechanisms. 2008. 1: 78-82. https://doi.org/10.1242/dmm.000976
  15. Shibata D, Hawes D, Stemmermann GN, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii. Cancer Epidemiology, Biomarkers & Prevention. 1993. 2: 213-217.
  16. Shin HR, Jung KW, Won YJ, Park JG, 139 KCCR-affiliated Hospitals. 2002 annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals. Cancer Research and Treatment. 2004. 36: 103-114. https://doi.org/10.4143/crt.2004.36.2.103
  17. Shridhar R, Almhanna K, Hoffe SE, Fulp W, Weber J, Chuong MD, Meredith KL. Increased survival associated with surgery and radiation therapy in metastatic gastric cancer: a Surveillance, Epidemiology, and End Results database analysis. Cancer. 2013. 119: 1636-1642. https://doi.org/10.1002/cncr.27927
  18. Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell. 2004. 5: 121-125. https://doi.org/10.1016/S1535-6108(04)00033-9
  19. van Beek J, zur Hausen A, Kranenbarg EK, Warring RJ, Bloemena E, Craanen ME, van de Velde CJ, Middeldorp JM, Meijer CJ, van den Brule AJ. A rapid and reliable enzyme immunoassay PCR-based screening method to identify EBV-carrying gastric carcinomas. Modern Pathology. 2002. 15: 870-877. https://doi.org/10.1097/01.MP.0000024147.43288.B1
  20. Yanagihara K, Seyama T, Tsumuraya M, Kamada N, Yokoro K. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Research. 1991. 51: 381-386.
  21. Yanagihara K, Tanaka H, Takigahira M, Ino Y, Yamaguchi Y, Toge T, Sugano K, Hirohashi S. Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. Cancer Science. 2004. 95: 575-582. https://doi.org/10.1111/j.1349-7006.2004.tb02489.x
  22. Yoo TH, Lee MH, Min Park1, Lee J, Woo HJ, Kim HW, Yang JY, Kwon HJ, Yeon MJ, Kim JB. Detection of EBV-encoded Small RNA from Diffuse Large B-cell Lymphoma Patients by RT-PCR Method. Biomedical Science Letters. 2015. 21:227-232. https://doi.org/10.15616/BSL.2015.21.4.227
  23. Young LS, Murray PG. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene. 2003. 22: 5108-5121. https://doi.org/10.1038/sj.onc.1206556